Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07264920 · ClinicalTrials.gov registry record · NA
Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain
A NA study, sponsored by Johns Hopkins University.
- Not yet
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT07264920: Clinical Trial NA study, sponsored by Johns Hopkins University.
NCT07264920 is a NA study that has not yet begun recruiting, run by Johns Hopkins University. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07264920, a NA study, has not yet begun recruiting, sponsored by Johns Hopkins University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This is a study evaluating the Scrambler Therapy device as a non-invasive treatment for neuropathic pain in pediatric oncology patients with metastatic bone disease. The primary goal is to assess changes in pain intensity and medication use, aiming to improve quality of life and reduce reliance on systemic pain medications.
Interventions
- DEVICE Scrambler Therapy MC-5A Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-08 |
| Est. Completion | 2030-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07264920
The ClinicalTrials.gov registry entry for NCT07264920 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Scrambler Therapy MC-5A Device is the first listed.
NCT07264920 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07264920 about?
NCT07264920 is a clinical study titled "Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain". This is a study evaluating the Scrambler Therapy device as a non-invasive treatment for neuropathic pain in pediatric oncology patients with metastatic bone disease. The primary goal is to assess changes in pain intensity and medication use, aiming to improve quality of life and reduce reliance on s...
What is the current status of trial NCT07264920?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-08. Estimated completion is 2030-01.
What interventions are being tested in trial NCT07264920?
The interventions under investigation include: Scrambler Therapy MC-5A Device (DEVICE).
Who is sponsoring clinical trial NCT07264920?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.